Atlas Trials

Clinical and Biological Effects of Anti-IgE (Omalizumab) in Patients With Bilateral Nasal Polyposis and Asthma

Clinical trial NCT01393340 · COMPLETED

Trial details

NCT number
NCT01393340
Sponsor
University Hospital, Ghent
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Nasal PolyposisAsthma
Start date
2006-12-01
Primary completion
2008-10-01
Enrollment
23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.